Trial · NCT06734637
Efficacy and Safety of Peginterferon in ET and PV.
NCT06734637, Not applicable, Recruiting, Zhenya Hong
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Efficacy and Safety of Peginterferon in ET and PV. Trials, record NCT06734637. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06734637
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Efficacy and Safety of Peginterferon in ET and PV.
- NCT number
- NCT06734637
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 40 participants, estimated
- Lead sponsor
- Zhenya Hong
- Conditions
- Essential Thrombocythemia, Polycythemia Vera
- Interventions
- Peginterferon α-2b injection
- First posted
- 2024-12-16
- Last updated
- 2024-12-16
Source ClinicalTrials.gov
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Hematologic remission rate | Week 12,24 | |
| Secondary | Molecular remission rate | Week 24,48 | |
| Secondary | Peripheral blood driver genes | Week 24,48 | |
| Secondary | Bone marrow-driven genes | Week 24,48 | |
| Secondary | The incidence of thrombosis | Week 24,48 | |
| Secondary | Incidence of bleeding events | Week 24,48 | |
| Secondary | The incidence of progression to myelofibrosis. | Week 24,48 | |
| Secondary | The incidence of acute leukemia. | Week 24,48 | |
| Secondary | Changes in the burden of driver gene mutations during maintenance therapy. | Week 24,48 | |
| Secondary | Hematologic remission | Week 48 |
1 to 10 of 11Source ClinicalTrials.gov
See all 11 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06734637
GET https://conductscience.org/api/trials/v1/NCT06734637/registered